相关实验视频
Updated: Jul 12, 2025

12:24
Murine Model of CD40-activation of B cells
Published on: March 5, 2010
12.7K
揭示CD40激进的潜力,以增强免疫检查点封锁的潜力
1The Ohio State University James Comprehensive Cancer Center and Division of Medical Oncology, Columbus, Ohio.
概括
CD40激素刺激免疫细胞创造瘤微环境,这可能会改善长期反应,当与免疫检查点阻塞疗法相结合时.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 治疗方法 治疗方法
背景情况:
- CD40激进症是一种治疗策略,可以激活抗原呈现细胞 (APC).
- 激活的APC刺激了效应性T细胞和自然杀手细胞 (NK细胞).
- 这种激活对于启动抗瘤免疫反应至关重要.
研究的目的:
- 讨论CD40激动因子在癌症治疗中的治疗潜力.
- 为了探索CD40激进症如何影响瘤微环境.
- 评估其与免疫检查点封锁的协同作用.
主要方法:
- 审查目前关于CD40激动症的研究.
- 讨论所涉及的免疫机制.
- 分析潜在的临床应用.
主要成果:
- CD40激动性可以促进干扰素激活的,T细胞炎症的瘤微环境.
- 这种改变的微环境可能会增强其他免疫疗法的疗效.
- 与免疫检查点抑制剂相结合时,可能产生持久反应.
结论:
- CD40激动性具有显著的治疗前景.
- 它可以克服对免疫检查点阻塞的抵抗力.
- 需要进一步的临床研究,以优化其在癌症治疗中的使用.
相关概念视频
Tumor Immunotherapy
538
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
538
T Cell Activation and Clonal Selection
764
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
764

